Carel A. van Baalen

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

Michèl R. Klein, Carel A. van Baalen, A M Holwerda et al. · The Journal of Experimental Medicine · 1995 · 639 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Cross-Recognition of Avian H5N1 Influenza Virus by Human Cytotoxic T-Lymphocyte Populations Directed to Human Influenza A Virus

Joost H. C. M. Kreijtz, Gerrie de Mutsert, Carel A. van Baalen et al. · Journal of Virology · 2008 · 232 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

Carel A. van Baalen, R. C. Huisman, Michèl R. Klein et al. · Journal of General Virology · 1997 · 195 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.

Rob van Binnendijk, Carel A. van Baalen, Martien C. M. Poelen et al. · The Journal of Experimental Medicine · 1992 · 126 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Sabine Allard, Brenda De Keersmaecker, Anna L. de Goede et al. · Clinical Immunology · 2011 · 119 citations

Life Sciences, Immunology, Infectious Diseases +17